awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42222934-AC9FB6D3-CDC2-4892-AE64-74C3D9798604
Q42222934-AC9FB6D3-CDC2-4892-AE64-74C3D9798604
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42222934-AC9FB6D3-CDC2-4892-AE64-74C3D9798604
Successful treatment with pemetrexed, Carboplatin, and bevacizumab for platinum-resistant adenocarcinoma of the lung.
P2860
Q42222934-AC9FB6D3-CDC2-4892-AE64-74C3D9798604
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42222934-AC9FB6D3-CDC2-4892-AE64-74C3D9798604
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e191f7458c4a44b92a7bd84d1b2cef8b9e2ad96c
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.